Crinetics Pharmaceuticals, Inc. — Form 8-K
Filed August 28, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
This 8-K reports Item 5.07 (stockholder vote submission) and Item 9.01 (exhibits only). The filing contains no substantive financial terms, counterparties, deal amounts, or business developments. It appears to be a routine procedural filing disclosing the submission of matters to a stockholder vote, with specific details not provided in the document header or accessible content.
Why this rating
Routine administrative disclosure; no material transaction, financing, or business change disclosed. Stockholder vote submission is procedural unless outcome materially affects operations.
Extracted items
- 5.07 shareholder vote
- 9.01 exhibits
See more from August 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.